1 December 2016 in Journal of Translational Medicine
Cyclin-dependent kinase inhibitor 2A/2B (CDKN2A/2B) near chromosome 9p21 have been associated with both atherosclerosis and artery calcification, but the underlying mechanisms remained largely unknown. Considering that CDKN2A/2B is a frequently reported site for DNA methylation, this study aimed to evaluate whether carotid artery calcification (CarAC) is related to methylation levels of CDKN2A/2B in patients with ischemic stroke. DNA methylation levels of CDKN2A/2B were measured in 322 ischemic stroke patients using peripheral blood leukocytes. Methylation levels of 36 CpG sites around promoter regions of CDKN2A/2B were examined with BiSulfite Amplicon Sequencing. CarAC was quantified with Agatston score based on results of computed tomography angiography. Generalized liner model was performed to explore the association between methylation levels and CarAC. Of the 322 analyzed patients, 187 (58.1%) were classified as with and 135 (41.9%) without evident CarAC. The average methylation levels of CDKN2B were higher in patents with CarAC than those without (5.7 vs 5.4, p = 0.001). After adjustment for potential confounders, methylation levels of CDKN2B were positively correlated with cube root transformed calcification scores (β = 0.591 ± 0.172, p = 0.001) in generalized liner model. A positive correlation was also detected between average methylation levels of CDKN2B and cube root transformed calcium volumes (β = 0.533 ± 0.160, p = 0.001). DNA methylation of CDKN2B may play a potential role in artery calcification.
1 June 2017 in Brain Research
Intraluminal middle cerebral artery occlusion (MCAO) is the most widely used model of stroke. We aimed to predict the outcome of MCAO using a combination of fine behavioural tests for the prediction of unsuccessful surgery in mice leading to no infarction, haemorrhage and unexpected death. MCAO was performed on adult mice under the guidance of laser-Doppler flowmetry (LDF) to warrant a decrease in regional cerebral blood flow (rCBF) in the MCA territory. Four outcomes of MCAO were defined according to histological analysis: infarction, no infarction, haemorrhage and unexpected death (death within 24h post-surgery). Fine behavioural tests including the rotarod, modified neurological severity score (mNSS), Clark general and Clark focal tests were performed separately at 6h, 12h and 24h post-stroke. A total of 94 mice were included in the analysis. The infarction rate associated with MCAO was 58.5% (55/94). After optimization of the timing and behavioural tests, we found that higher Clark focal (>17.5) or higher mNSS scores (>10) were markedly related to early death, whereas a lower mNSS score (<3.5) was indicative of a tendency to show no infarction at 6h post-stroke. After 24h post-stroke, there was a positive correlation between the infarct volume and Clark focal results. Behavioural tests could help to predict the outcomes in the MCAO mouse model.
1 October 2014 in Brain Research Bulletin
25 January 2017 in BMC Anesthesiology
The association between CD14-159C/T polymorphism and sepsis has been assessed but results of current studies appeared conflicting and inconstant. This analysis was aimed to determine whether the CD14-159C/T polymorphism confers susceptibility to sepsis or is associated with increased risk of death from sepsis. The authors conducted a comprehensive search of PubMed, EMBASE, ISI Web of Science, Cochrane library, ScienceDirect, Wiley Online Library and CNKI databases according to a prespecified protocol. Language limits were restricted to English and Chinese. Two reviewers independently selected the articles and extracted relevant data onto standardized forms. Disagreements were settled by discussion and suggestions from senior consultants. The strength of association were evaluated by odds ratio (OR) and 95% confidence interval (CI). Studies failed to fit the Hardy-Weinberg-Equilibrium were excluded. The research identified a total of 2317 full-text articles of which 14 articles met the predefined inclusion criteria. Meta-analysis was performed for allele frequency of C versus T, as well as genotypes CC + CT versus TT (dominant model), CC versus TT + CT (recessive model), CT versus TT and CC versus TT (additive model). All control samples were in Hardy-Weinberg proportion. No significant association between CD14-159C/T polymorphism and sepsis susceptibility or mortality were detected in the overall population. Nonetheless, subgroup analysis of Asian ethnicity revealed significant association between the CD14-159C/T polymorphism and susceptibility to sepsis in additive model (CC versus TT: OR = 0.52, 95% CI 0.29–0.92, p = 0.03) and recessive model (CC versus CT + TT: OR = 0.50, 95% CI 0.30–0.84, p = 0.009). Of note, three out of the five papers included in the subgroup focused exclusively on burn ICU patients. This meta-analysis demonstrated that CD14-159C/T polymorphism is likely to be associated with susceptibility to sepsis in Asian population, especially for the TT genotype. However, bias may rise for etiologic reasons because the majority of subjects in the subgroup came from burn ICU. CD14-159C/T polymorphism is not relevant to sepsis mortality in any genetic models, regardless of the ethnicities. Due to the exploratory nature of the study, no adjustment for multiple testing was adopted, and therefore the results should be interpreted with precaution. Well-designed studies with larger sample size and more ethnic groups are required to further validate the results.
9 March 2026 in BMC Neurology
Background: Acute lithium toxicity can cause cerebellar impairment, but long-term follow-up data are limited. We describe a case of acute lithium intoxication followed by progressive cerebellar atrophy and permanent cerebellar dysfunction. Case presentation: Five years ago, a previously healthy 38-year-old man developed a clinical syndrome consistent with neuroleptic malignant syndrome (NMS)-like syndrome in the setting of acute lithium and quetiapine toxicity. On admission, the serum lithium concentration was 4.07 mmol/L and the cerebrospinal fluid lithium concentration was 2.45 mmol/L. Continuous renal replacement therapy (CRRT) was initiated, and cerebrospinal fluid lavage was also performed as documented in the outside hospital records. Serum lithium levels subsequently decreased to below 0.2 mmol/L. After treatment, consciousness improved. However, he developed a persistent cerebellar syndrome, characterized by ataxia, gait instability, and dysarthria. Brain magnetic resonance imaging one year later revealed cerebellar atrophy. Over five years of follow-up, severe ataxia persisted, and serial MRI showed progressive isolated cerebellar atrophy without supratentorial structural abnormalities. Conclusions: This case suggests that severe acute lithium toxicity may be associated with progressive cerebellar degeneration, even after normalization of serum lithium levels. Clinicians should consider long-term follow-up for neurological sequelae in individuals suffering from acute lithium intoxication.
22 January 2018 in Stroke
Introduction: There is a widespread belief that Asian population is more susceptible to bleeding, which limits the use of t-PA in patients with ischemic stroke (AIS) in China because of the fear of hemorrhagic transformation (HT). However, this has not been examined in clinical practice. We undertook the current study to compare the incidence of symptomatic HT (SHT) among thrombolysis-treated AIS patients in 2 academic institutions in China and United States. Methods: We compared the clinical and radiological features of 191 consecutive patients treated with IV t-PA within 4.5h of onset ± endovascular therapy from an American (ASC; n = 86) and a Chinese stroke centers (CSC; n = 105). SHT was defined using various definitions based on the NINDS t-PA, ECASS-2, and a modified version of SITS-MOST study (mSITS-MOST) criteria. We used penalized logistic regression to adjust for confounding variables and to identify predictors of SHT. Results: ASC patients were older; had higher prevalence of women; diabetes, hypertension, and cardiac disease; and use of anti-thrombotics and statins. They also had higher baseline serum glucose, shorter onset-to-treatment time, and fewer endovascular interventions. However, none of these emerged as independent predictor of SHT. On logistic regression, there was a trend for an association between baseline serum glucose and the risk of SHT in the ACS population (p=0.056), but not the CSC cohort (p=0.119). The rates of SHT were higher in the ASC cohort compared to the CSC cohort, as follows: 18.6% vs. 13.9% based on NINDS definition of SHT; 15.1% vs. 11.9% based on ECASS-2; and 11.6% vs. 5.0% based on mSITS-MOST. Despite higher rates of SHT in the ASC, fatal HT occurred in only 5.9% of cases vs. 7.9% in CSC cases. However, none of these differences were significant (unadjusted and adjusted p values >0.05). Conclusions: Contrary to perceived notions that HT is more common in AIS Chinese patients, we found that the rate of SHT after t-PA is equivalent between Chinese and North American stroke patients. Our findings require further confirmation in a larger and multi-institutional cohort of patients. Similar results could have a positive impact on increased use of t-PA for AIS in China and other Asian countries.